SARAH DAVIDSON: Open Payments
NPI 1437578648 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,668 in 105 payments from 23 companies in 2025. Trend: 2023 $1,230 · 2024 $1,539 · 2025 $1,668
Food & beverage: $1,668
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $254 |
| Novo Nordisk Inc | 15 | $214 |
| Amgen Inc. | 23 | $207 |
| GlaxoSmithKline, LLC. | 8 | $148 |
| PFIZER INC. | 11 | $139 |
| Axsome Therapeutics, Inc. | 4 | $101 |
| Abbott Laboratories | 4 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
Products named: OTEZLA, VRAYLAR, Wegovy, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, NURTEC ODT, Ozempic, REXULTI.
Industry payments across TX — which companies pay providers there.
